Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

Kulkarni Jayashri

首页> 外文期刊>The Australian and New Zealand journal of psychiatry >Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

【24h】

Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

机译：精神病学中的药物替代科学 - 治疗用品管理和食品和药物管理局利用的临床创新

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Australian and New Zealand journal of psychiatry》 |2017年第1期|共2页
作者
Kulkarni Jayashri;
展开▼
作者单位

Monash Alfred Psychiat Res Ctr Level 4 607 St Kilda Rd Melbourne Vic 3004 Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration [J] . Kulkarni Jayashri The Australian and New Zealand journal of psychiatry . 2017,第1期

机译：精神病学中的药物替代科学 - 治疗用品管理和食品和药物管理局利用的临床创新
2. A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring [J] . Brett Fleisher, Sihem Ait-Oudhia OncoTargets and therapy . 2017,第2期

机译：对美国食品和药物管理局对肿瘤生物制剂的临床药理学评论的回顾性检查，以用于治疗药物监测的潜在用途
3. ASSESSMENT OF NARROW THERAPEUTIC INDEX (NTI) DRUGS BY THE NARROW THERAPEUTIC INDEX (NTI) WORKING GROUP AT THE US FOOD AND DRUG ADMINISTRATION (FDA). [J] . Zhao L., Donnelly M., Fang L., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：美国食品和药物管理局（FDA）窄治疗指数（NTI）工作组对窄治疗指数（NTI）药物的评估。
4. Clinical Exotic Animal Applications for F10 Germicidal Wound Spray with Insecticide: A Novel Agent in the USA - A Recent Addition to the Food and Drug Administration's Minor Use and Minor Species Inde [C] . Annual Conference and Expo of the Association of Avian Veterinarians . 2017

机译：F10杀虫剂伤口喷雾用杀虫剂的临床外来动物应用：美国新型药剂 - 最近的食品和药物管理局的轻微使用和次要物种Inde
5. Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving US Food and Drug Administration Premarket Approval in 2010 and 2011. [D] . Rathi, Vinay Kumar. 2016

机译：在2010年和2011年获得美国食品药品监督管理局上市前批准的高风险治疗性医疗器械整个产品生命周期中进行的临床研究。
6. A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring [O] . Brett Fleisher, Sihem Ait-Oudhia 2018

机译：对美国食品药品监督管理局对肿瘤生物制剂的临床药理学评论的回顾性检查以用于治疗药物监测的潜在用途
7. Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels [O] . Bo Wang, William J. Canestaro, Niteesh K. Choudhry 2014

机译：支持美国食品和药物管理药物标签中提供药物替代品生物标志物检测的临床证据
8. Food and Drug Administrations's Oversight of Clinical Investigators' Financial Information [R] . 2009

机译：美国食品和药物管理局对临床调查员财务信息的监督

Pharmacogenomics in psychiatry - Clinical innovation utilised by the Therapeutic Goods Administration and Food and Drug Administration

著录项

相似文献

相关主题

期刊订阅